2025-04-01 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Report

**0) Executive Summary:**

UnitedHealth Group Inc (UNH) is a diversified healthcare company providing a range of products and services.  This report analyzes UNH's performance against the S&P 500 (VOO), considering its recent price movements, financial statements, and key indicators.  The analysis suggests strong historical performance but cautions about recent volatility.

**1) Performance Comparison with S&P 500 (VOO):**

UNH's cumulative return is significantly higher than the S&P 500's.

* **UNH Cumulative Return:** 109.95%
* **VOO Cumulative Return:** 91.19%
* **Return Difference:** 18.76%
* **Relative Divergence:** 24.3% (This indicates UNH's outperformance relative to its historical range against the S&P 500)

The provided alpha and beta analysis reveals considerable variability in performance across different time periods.  While exhibiting a generally higher return than the market (positive alpha), the beta suggests sensitivity to overall market fluctuations.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 62.0% | 5.8% | 44.0% | 0.0 | 183.6 |
| 2016-2018  | 53.0% | 50.8% | 47.0% | 0.2 | 210.2 |
| 2017-2019  | 40.0% | 50.8% | 21.0% | 0.1 | 252.3 |
| 2018-2020  | 12.0% | 50.8% | -22.0% | 0.2 | 305.9 |
| 2019-2021  | 74.0% | 24.0% | 1.0% | 0.2 | 444.2 |
| 2020-2022  | 80.0% | 49.7% | 69.0% | 0.3 | 475.0 |
| 2021-2023  | 56.0% | 49.7% | 38.0% | 0.3 | 478.8 |
| 2022-2024  | -16.0% | 49.7% | -39.0% | 0.3 | 467.3 |
| 2023-2025  | -10.0% | 55.9% | -53.0% | 0.2 | 478.4 |


**2) Recent Price Movement:**

* **Closing Price:** $515.72
* **Last Market Price:** $523.27
* **5-Day Moving Average:** $516.14
* **20-Day Moving Average:** $493.86
* **60-Day Moving Average:** $509.09

The price is currently above all three moving averages, suggesting a potential upward trend, although the recent increase (Last-market data) shows a small, 1.4% jump that might be considered a minor upswing.

**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4283 (Medium Risk)
* **RSI:** 67.51 (Approaching overbought territory)
* **PPO:** 0.91 (Positive, suggesting upward momentum)
* **20-Day Relative Divergence Change:** +1.1 (Short-term upward trend)

The relatively high RSI and positive PPO, coupled with the recent price increase, suggest that the stock price is in an upward trend, but near the overbought zone and closer monitoring is required.

* **Expected Return:** 170.5% (This represents the projected long-term (2+ years) excess return over the S&P 500 with consistent investment, a high number requiring careful consideration given inherent risk and market volatility)

**4) Recent Earnings Analysis:**

| Date       | EPS     | Revenue       |
|------------|---------|---------------|
| 2024-11-04 | 6.56    | $100.82 B     |
| 2024-08-09 | 4.58    | $98.86 B     |
| 2024-05-09 | -1.53   | $99.80 B     |
| 2023-11-06 | 6.31    | $92.36 B     |
| 2024-11-04 | 6.31    | $92.36 B     | *(Duplicate entry, likely an error)*


Revenue remains relatively stable, but EPS shows significant variability, including a substantial negative EPS in Q2 2024.  This volatility needs further investigation to understand the underlying causes.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|------------|---------------|
| 2024-12-31 | $100.81B  | 21.14%        |
| 2024-09-30 | $100.82B  | 22.84%        |
| 2024-06-30 | $98.86B   | 22.31%        |
| 2024-03-31 | $99.80B   | 23.05%        |
| 2023-12-31 | $94.43B   | 23.30%        |

Revenue is consistently high and showing slight growth. Profit margins are strong but have fluctuated over recent quarters.


**Capital and Profitability:**

| Quarter | Equity     | ROE     |
|---------|------------|---------|
| 2024-12-31 | $92.66B   | 5.98%   |
| 2024-09-30 | $94.53B   | 6.41%   |
| 2024-06-30 | $89.36B   | 4.72%   |
| 2024-03-31 | $86.69B   | -1.63%  |
| 2023-12-31 | $88.76B   | 6.15%   |

Equity shows some variability, and ROE reflects the impact of the negative EPS in Q1 2024.

**6) Overall Analysis:**

UNH has demonstrated strong historical performance, significantly outperforming the S&P 500.  However, recent quarters show some volatility in earnings, which needs further investigation.  While current indicators suggest potential upward momentum, the high RSI and variability in key metrics suggest a need for caution.  The exceptionally high projected long-term return needs critical assessment of the associated risk.  Further due diligence, including analysis of the causes for the negative EPS in Q2 2024 and the general volatility, is recommended before making any investment decisions.  The data provided has some inconsistencies (duplicate entry) that require clarification.
